Dr. Anthony C. Feghali, MD

Dr. Feghali practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Feghali's NPI, 1134486509, was assigned on April 23, 2012. Dr. Feghali graduated from George Washington University School of Medicine in 2012. Dr. Feghali holds New York license 298669.

Dr. Feghali's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Feghali's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Feghali is also affiliated with Oswego Hospital. The medical group on file is University Surgical Associates. Dmand AI also links Dr. Feghali to 2 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feghali practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Feghali's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Feghali is licensed in New York.

CMS data shows 553 Medicare services from Dr. Feghali across 11 procedure codes in 2024, for 497 Medicare patients. Medicare paid $38,560 for them.

CMS counts 497 Medicare patients who saw Dr. Feghali in 2024. The largest group is 65 to 74, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feghali's median patient age at 64, with 49% women.

In 2024, Dr. Feghali wrote 64 Medicare Part D claims for 18 patients. 92% of them were for generic drugs. CMS names the drug for 36 of them, across 1 drug with 11 or more claims each, at $232 in total drug cost. In 2023, CMS named 54 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Feghali for performance year 2024, reported as part of a group. Dr. Feghali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feghali as offering telehealth. CMS counts 18 procedures of removal of tissue by Dr. Feghali, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Feghali, published from 2015 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Blood Vessel Prosthesis Implantation and Endovascular Procedures. Dr. Feghali has published most often in J Vasc Surg Cases Innov Tech. Dr. Feghali's most frequent co-authors are Babak Abai, MD, Deena Basima Chihade, MD and Dawn Maria Salvatore, MD.

CMS Open Payments shows 510 general payments to Dr. Feghali from 24 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 48% of the total. Endologix, Inc. paid the most, $97,825.

Dr. Feghali graduated from George Washington University School of Medicine in 2012.